Want to join the conversation?
Biopharma company $AMGN and UCB SA said topline results from Phase 3 fracture study in postmenopausal women with osteoporosis (FRAME study) showed that women receiving subcutaneous injection of romosozumab monthly experienced a 73% reduction in risk of a vertebral fracture through 12 months versus those receiving placebo.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?